3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
20
Leukemia, Myeloid, Acute
20
Lymphoma, Non-Hodgkin
14
Congenital Abnormalities
14
Multiple Myeloma
13
Leukemia, Lymphocytic, Chronic, B-Cell
11
Leukemia
11
Myelodysplastic Syndromes
10
Lymphoma, Mantle-Cell
9
Hodgkin Disease
9
Lymphoma, Large B-Cell, Diffuse
8
Lymphoma
8
Lymphoma, Follicular
7
Lymphoma, B-Cell, Marginal Zone
7
Leukemia, Myeloid, Accelerated Phase
7
Waldenstrom Macroglobulinemia
6
Anemia, Refractory, with Excess of Blasts
6
Sezary Syndrome
5
Recurrence
5
Myeloproliferative Disorders
5
Mycosis Fungoides
5
Lymphoma, T-Cell, Cutaneous
5
Lymphoma, Large-Cell, Immunoblastic
5
Leukemia, Myelomonocytic, Chronic
5
Leukemia, Myeloid, Chronic-Phase
5
Graft vs Host Disease
5
Burkitt Lymphoma
5
Lymphoma, Extranodal NK-T-Cell
4
Leukemia, Myelomonocytic, Juvenile
4
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
4
Interventions
Microbial Collagenase
15
xiapex
10
Collagenases
4
Surgical Procedures, Operative
2
Sodium Chloride
2
Triamcinolone Acetonide
1
Transplantation
1
Tranexamic Acid
1
Therapeutics
1
Surveys and Questionnaires
1
Restraint, Physical
1
Radiotherapy
1
Oxycodone
1
Ibuprofen
1
High-Energy Shock Waves
1
Extracorporeal Shockwave Therapy
1
Enzymes
1
Dexamethasone
1
Adrenal Cortex Hormones
1
Adalimumab
1
Acetaminophen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Dupuytren Contracture
×
Transplantation
×
Clear all
NCT05067764
2026-04-23
REMEDY
Elsan
Phase NA
Recruiting
172 enrolled